These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38804761)

  • 1. Pharmacotherapy for Adults With Alcohol Use Disorder.
    Bruehlman A; Salisbury-Afshar E
    Am Fam Physician; 2024 May; 109(5):459-462. PubMed ID: 38804761
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving.
    Soyka M
    Evid Based Ment Health; 2013 Aug; 16(3):71. PubMed ID: 23604277
    [No Abstract]   [Full Text] [Related]  

  • 3. More Treatments on Deck for Alcohol Use Disorder.
    Lyon J
    JAMA; 2017 Jun; 317(22):2267-2269. PubMed ID: 28538998
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy for Adults with Alcohol Use Disorder.
    Salisbury-Afshar E
    Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
    [No Abstract]   [Full Text] [Related]  

  • 5. Alcohol dependence and pharmacologic treatment. Introduction.
    McDonough KP
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S3-4. PubMed ID: 17322180
    [No Abstract]   [Full Text] [Related]  

  • 6. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
    Abraham AJ; Knudsen HK; Roman PM
    J Stud Alcohol Drugs; 2011 Jul; 72(4):669-77. PubMed ID: 21683049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of alcoholism--10 years of progress.
    Anton RF
    Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):172A-175A. PubMed ID: 8947259
    [No Abstract]   [Full Text] [Related]  

  • 9. Naltrexone in alcohol dependence.
    Brewer C
    Lancet; 1995 Nov; 346(8986):1374. PubMed ID: 7475809
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for alcohol dependence.
    West SL; Garbutt JC; Carey TS; Lux LJ; Jackman AM; Tolleson-Rinehart S; Lohr KN; Crews FT
    Evid Rep Technol Assess (Summ); 1999 Jan; (3):1-5. PubMed ID: 11487800
    [No Abstract]   [Full Text] [Related]  

  • 13. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 14. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders.
    Chokron Garneau H; Venegas A; Rawson R; Ray LA; Glasner S
    J Subst Abuse Treat; 2018 Feb; 85():34-37. PubMed ID: 28527854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Naltrexone in the treatment of alcohol dependence].
    Ochoa Mangado E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):51-7. PubMed ID: 9549136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anesthetic considerations in a patient taking disulfiram and naltrexone for chronic alcoholism].
    del Blanco Narciso BB; Orts Castro A; Calvo Vecino JM
    Rev Esp Anestesiol Reanim; 2011 Feb; 58(2):128-9. PubMed ID: 21427831
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug reduces alcohol craving.
    Nurse Pract; 1999 Feb; 24(2):104. PubMed ID: 10048082
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging approaches to managing alcohol dependence.
    Swift R
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S12-22. PubMed ID: 17322178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.